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Abstract
 
Regulatory T cells (Tregs) fulfill a central role in immune regulation. We reported previously
that the integrin 
 
 
 
E
 
 
 
7
 
 discriminates distinct subsets of murine CD4
 
 
 
 regulatory T cells. Use of
this marker has now helped to unravel a fundamental dichotomy among regulatory T cells.
 
 
 
E
 
 
 
CD25
 
 
 
 cells expressed L-selectin and CCR7, enabling recirculation through lymphoid tissues.
In contrast, 
 
 
 
E
 
-positive subsets (CD25
 
 
 
 and CD25
 
 
 
) displayed an effector/memory phenotype
expressing high levels of E/P-selectin–binding ligands, multiple adhesion molecules as well as
receptors for inflammatory chemokines, allowing efficient migration into inflamed sites. Accord-
ingly, 
 
 
 
E
 
-expressing cells were found to be the most potent suppressors of inflammatory processes
in disease models such as antigen-induced arthritis.
Key words: CD103 • CD25 • lymphocyte migration • chemokines • inﬂammation
 
Introduction
 
A large body of recent data demonstrates that CD4
 
 
 
 regu-
latory T cells (Tregs) are important in the maintenance of
immunological homeostasis and self-tolerance (for review
see reference 1). Although a universal master switch for
generation and function of Tregs was apparently found
recently with the identification of Foxp3 (2), the origin of
various types of Tregs is currently unclear. CD25
 
 
 
CD4
 
 
 
Tregs appear to be generated as a unique lineage of T cells
within the thymus, as in adult day 3 thymectomized animals
the development of multi-organ autoimmunity is corre-
lated with a reduced number of CD25
 
 
 
CD4
 
 
 
 Tregs in
peripheral lymphoid tissues (3). Moreover, a suppressive
capacity was demonstrated for the CD25
 
 
 
 subset of
CD4
 
 
 
CD8
 
 
 
 thymocytes (4, 5). In TCR-transgenic systems,
high frequencies of CD25
 
 
 
CD4
 
 
 
 Tregs were only found if
the model antigen was expressed within the thymus (6, 7).
This suggests that self-reactive Tregs are generated during
normal T cell development within the thymus. On the
other hand, peripheral induction of suppressive CD4
 
 
 
 T cells
from naive T cells has also been reported. Antigen-specific
CD25
 
 
 
CD4
 
 
 
 T cells generated upon antigen exposure under
tolerogenic conditions were functionally indistinguishable
in several assays from endogenous CD25
 
 
 
CD4
 
 
 
 T cells (8,
9) and have been shown to play a role in transplantation
tolerance (10). The concept of “natural” and “adaptive”
regulators proposed recently (11) addresses the diversity of
Tregs with respect to function and development.
Where Tregs act and how they migrate in vivo has
hardly been studied so far. The capacity of Tregs to suppress
activation and proliferation of naive T cells (12) suggests
that they act in a lymphoid environment. Accordingly,
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L-selectin, which is required for entry into lymph nodes,
has been found on the majority of CD25
 
 
 
 Tregs (13, 14).
Other papers report the presence of receptors for inflam-
matory chemokines (CCR2, CCR4, CCR5, and CCR8)
and increased levels of adhesion molecules (CD54 and
LFA-1) on regulatory subsets (5, 13, 15, 16), suggesting
that these cells are able to enter inflamed tissues and might
act directly at sites of inflammation (17). However, a com-
prehensive analysis on trafficking properties of Tregs in
vivo is still lacking.
We and others have identified the integrin 
 
 
 
E
 
 
 
7
 
 as a
marker for highly potent regulatory CD4
 
 
 
 T cells isolated
from murine secondary lymphoid organs (18–20). The
integrin not only subdivides the “classical” regulatory
CD25
 
 
 
 compartment into two subsets (
 
 
 
E
 
 
 
CD25
 
 
 
 and
 
 
 
E
 
 
 
CD25
 
 
 
) but also identifies unique CD25
 
 
 
 suppressor T
cells (
 
 
 
E
 
 
 
CD25
 
 
 
) with characteristic properties (18).
In the present work, by analyzing adhesion molecule and
chemokine receptor expression as well as migration under
homeostatic and inflammatory conditions, we show that
the 
 
 
 
E
 
/CD25-defined subsets display distinct homing
properties: CD25 single positive cells (
 
 
 
E
 
 
 
CD25
 
 
 
) prefer-
entially recirculate through lymph nodes, whereas 
 
 
 
E
 
-posi-
tive CD4
 
 
 
 T cells represent inflammation-seeking Tregs.
The functional importance of the aforementioned diversity
is underlined by the unique immunosuppressive capacity of
 
 
 
E
 
-positive regulators in models of acute and chronic in-
flammation. Thus, the findings of this paper define differ-
ences in developmental stage, trafficking properties, and
functional activity among suppressors, which provide a
conclusive framework for understanding how specialized
subsets of Tregs might fulfill divergent tasks in homeostasis
and control of ongoing immune reactions.
 
Materials and Methods
 
Mice.
 
Female Balb/c and C57Bl6 mice were bred in the
Bundesinstitut für Risikobewertung in Berlin, Germany or pur-
chased from Charles River and used at 6–12 wk of age. All ani-
mal experiments were performed under specific pathogen-free
conditions and in accordance with institutional, state, and federal
guidelines.
 
Antibodies, Staining and Sorting Reagents.
 
The following anti-
bodies were produced in our laboratory: anti–FcR II/III (2.4G2),
anti-CD3 (145.2C11), anti-CD28 (37.51), FITC- and Cy5-
labeled anti-CD4 (GK1.5), FITC-labeled anti–CD4-F(ab) (GK1.5),
biotinylated anti-
 
 
 
E
 
 (M290), and biotinylated anti–
 
 
 
E
 
-F(ab)
 
2
 
(M290). The anti–
 
 
 
E
 
-Ab–producing hybridoma was provided by
P. Kilshaw (The Babraham Institute, Cambridge, UK). The re-
combinant P-selectin– and E-selectin–human IgG fusion proteins
were provided by D. Vestweber (University Muenster, Muenster,
Germany) and PE-labeled anti–inducible costimulator (ICOS) an-
tibody (MIC-280) by R. Kroczek (Robert Koch Institute, Berlin,
Germany). PE- and Cy5-labeled anti–human IgG antibodies were
obtained from Jackson ImmunoResearch Laboratories. The fol-
lowing antibodies and secondary reagents were purchased from
BD Biosciences: anti-CD4 (RM4–5), anti-CD8
 
 
 
 (Ly-2), anti-
CD25 (7D4), anti-CD25 (PC61), anti-CD29 (Ha2/5), anti-CD44
(IM7), anti-CD45RB (16A), anti-CD54 (3E2), anti–L-selectin
(Mel-14), anti-CD69 (H1.2F3), anti-
 
 
 
4
 
 
 
7
 
 (DAKT32), anti-CD11a
(2D7), streptavidin (SA), and appropriate isotype controls. All mi-
crobeads were obtained from Miltenyi Biotec.
 
Sorting of Treg Subsets.
 
T cell subsets were isolated from
spleen and peripheral and mesenteric lymph nodes of Balb/c
mice. Erythrocyte-depleted cell suspensions were stained with
anti–CD25-FITC and biotinylated anti-
 
 
 
E
 
 followed by PE-
labeled SA. All stained cells were isolated using anti-PE and anti-
FITC microbeads and the AutoMACS magnetic separation
system (Miltenyi Biotec). Subsequently, CD4
 
 
 
 subsets were sepa-
rated according to 
 
 
 
E
 
 and CD25 expression with FACS
 
®
 
 (DIVA;
BD Biosciences). All sorted subsets were 
 
 
 
90–95% pure on re-
analysis (Fig. S1 A available at http://www.jem.org/cgi/content/
full/jem.20031562/DC1).
 
DNA Microarray Hybridization and Analysis.
 
Total RNA was
purified from 2 
 
 
 
 10
 
6
 
 sorted cells and applied for DNA microar-
ray analysis as described in supplemental Materials and Methods.
 
Real-Time Quantitative RT-PCR Assay.
 
Real-time quantita-
tive RT-PCR for Foxp3 and chemokine receptors was per-
formed as described in supplemental Materials and Methods.
 
Quantification of TRECs by Real-Time PCR.
 
High molecular
weight DNA was extracted from the encoded samples of sorted T
cells from Balb/c mice using the QIAamp DNA Mini Kit
(QIAGEN). The T cell receptor excision circle (TREC) number
was determined by quantitative real-time PCR using the se-
quence detector TaqMan (ABI PRISM model 7700; PE Biosys-
tems) (for details, see supplemental Materials and Methods).
 
Flow Cytometry.
 
Cytometric analysis was performed as de-
scribed previously (21) using a FACSCalibur™ or an LSR (BD
Biosciences) and the CELLQuest™ software. Dead cells were ex-
cluded by propidium iodide or diamidophenylindole staining
(Sigma-Aldrich).
 
Chemotaxis Assay.
 
T cells were enriched from lymph node
and spleen cells of Balb/c mice by B cell depletion on anti-Ig–
coated plates (DakoCytomation) and subjected to chemotaxis
without further subset isolation or treatment. For the determina-
tion of the differential migration rates of the subsets, their fre-
quency and absolute number was analyzed by FACS
 
®
 
 in the in-
put as well in the migrated populations as described previously
(22). The recombinant murine chemokines CCL19, CCL20, and
CXCL9 were purchased from R&D Systems, and CCL17 was
purified from transfected insect cells, provided by I. Foerster (In-
stitute for Medical Microbiology, Munich, Germany). All che-
mokines were titrated to identify optimal concentrations.
 
Adoptive Transfer of Treg Subsets for Analysis of Migration Behavior
(Homing).
 
For in vivo homing assays, Treg subsets were isolated
from lymphoid organs of Balb/c or C57Bl6 mice (arthritis
model). A modified isolation method with a combination of neg-
ative selection and preferential use of Fab fragments was used:
CD4
 
 
 
 T cells were enriched by panning using anti-CD8– and
anti-Ig–coated plates. The subsets were separated by staining with
FITC-labeled anti–CD4-F(ab), biotinylated 
 
 
 
E
 
-F(ab)
 
2
 
, PE-
labeled SA and allophycocyanin-labeled anti-CD25 with FACS
 
®
 
(DIVA; BD Biosciences; MoFlow; DakoCytomation). Control
experiments demonstrated that the sorting procedure or the types
of antibodies chosen for staining did not significantly influence
the migration behavior of labeled cells. Purity of the sorted sub-
sets varied from 
 
 
 
98% for 
 
 
 
E
 
 
 
CD25
 
 
 
, 85–93% for 
 
 
 
E
 
 
 
CD25
 
 
 
,
80–94% for 
 
 
 
E
 
 
 
CD25
 
 
 
, and 70–85% for 
 
 
 
E
 
 
 
CD25
 
 
 
 (Fig. S1 B).
Cells were labeled with 
 
111
 
In (Indiumoxin) or [
 
51
 
Cr]chromate
(Amersham Biosciences) for 20 min at room temperature (2 
 
 
108 cells/ml; 10  Ci/ml) or for 1 h at 37 C (2   107 cells/ml; 20
 Ci/ml), respectively, followed by a 1-h incubation at 37 C in
fresh medium and removal of dead cells on Nycodenz (17.1% iso-Huehn et al. 305
tonic Nycodenz; Nyegaard). Labeled cells were injected i.v., and
24 h later, mice were killed and the distribution of radioactivity
in different organs, serum, and the remaining body was measured
in a  -counter (Wallac Counter).
DNFB-induced Skin Inflammation. Balb/c mice were sensi-
tized to 2,4-dinitrofluorobenzene (DNFB; Sigma-Aldrich) by
skin painting on the abdomen with a solution of 0.5% DNFB in
acetone–olive oil (4:1) at days  21 and  20. 24 h before the
homing assay, the immunized mice were challenged with 0.5%
DNFB at one ear pinna, whereas the untreated ear served as an
internal control.
Antigen-induced Arthritis. Arthritis was induced according to
Brackertz et al. (23). In brief, C57Bl6 mice were immunized by
subcutaneous injection of 100  g (2 mg/ml) methylated BSA
(mBSA; Sigma-Aldrich) in complete Freund’s adjuvant (Sigma-
Aldrich) 21 and 14 d before arthritis induction. Simultaneously,
mice received 2   109 killed Bordetella pertussis bacteria i.p. (Chi-
ron Corp.). Arthritis was induced by injection of 25  l of sterile
mBSA-solution (4 mg/ml in saline) into one knee joint cavity.
Clinical severity of arthritis was evaluated by measurement of
lateral joint diameter with an Oditest micrometer gauge (Kröplin
Längenmesstechnik) and calculated as difference between the ar-
thritic and untreated knee joint diameter. For histological evalua-
tion, knee joints were fixed, decalcified in EDTA, and embedded
in paraffin. Sections were stained with hematoxilin eosin. Six sec-
tions per knee joint were examined and scored blindly by two in-
vestigators on a 0–3 point basis for the extent of inflammatory
changes (lining layer hyperplasia and cellular infiltration of syn-
ovial tissue) and joint destruction (pannus formation and cartilage
destruction). A final arthritis score was evaluated for each animal
by calculating the sum of the individual points.
Adoptive Transfer of Treg Subsets for Suppression of Arthritis.
CD4  Treg subsets from lymph nodes and spleens of C57Bl6 mice
were separated on a FACS® (DIVA; BD Biosciences) after MACS-
enrichment of  E and CD25-expressing cells as aforementioned.
 E
 CD25 CD4  control cells were isolated from the magnetic
bead-negative fraction using MACS technology. All sorted subsets
were  95–98% pure on reanalysis (unpublished data).
Before adoptive transfer, all CD4  T cell subsets were preacti-
vated for 24 h with 3  g/ml plate-bound anti-CD3 plus 10  g/
ml of soluble anti-CD28 and 40 ng/ml recombinant murine IL-2
(R&D Systems) at 106 cells/ml. Cell culture was done with
RPMI 1640 (GIBCO BRL) supplemented with 10% FCS
(Sigma-Aldrich). Preactivated cells were gently removed from the
plates, extensively washed with PBS, and 200  l cell suspension
(5   105 cells/ml in PBS) was i.v. injected.
Statistics. Data were presented as mean   SD. In case of che-
motaxis, data were corrected for differences in the general migra-
tion activity between experiments by normalization to the aver-
age migration rate. Significance was determined by Student’s t
test (after testing normal distribution, chemotaxis assay), Wil-
coxon test (phenotyping, homing), Mann-Whitney-U (arthritis
score), and repeated measure analyses (knee joint swelling). Dif-
ferences were considered statistically significant with P   0.05
and highly significant with P   0.01. In case of multiple sample
comparisons, adjusted significance levels according to Bonferroni
were applied or overall significance was tested in advance with
the Kruskall-Wallis or Friedman test.
Online Supplemental Material. Fig. S1 shows the purity of
sorted Treg subsets used for gene expression analysis and homing
assays. Fig. S2 summarizes all genes being differentially expressed
between  E
 CD25 ,  E
 CD25 , and  E
 CD25  CD4  T cells.
Table SI depicts real-time quantitative RT-PCR data for the ex-
pression of chemokine receptors within the investigated Treg sub-
sets. Fig. S3 demonstrates that the differential expression of adhe-
sion molecules and the in vivo migration behavior of the Treg
subsets is not changed upon in vitro preactivation, and that the pre-
activation step does not result in differential survival. Fig. S4 shows
the histological examination of knee joints from the antigen-
induced arthritis model. Online supplemental material is available
at http://www.jem.org/cgi/content/full/jem.20031562/DC1.
Results
Divergent Developmental Stages of Treg Subsets. To ob-
tain a comprehensive picture of the phenotype and devel-
opmental stage of  E-expressing Tregs in comparison to
CD25 single positive cells, we applied cDNA microarray
technology for gene expression profiling of  E
 CD25 ,
 E
 CD25 , and  E
 CD25  CD4  T cell subsets isolated
directly ex vivo from secondary lymphoid organs. From
 12,400 murine full-length genes and expressed sequence
tags that were analyzed on Affymetrix microarrays,  90
(without expressed sequence tags) proved to be differen-
tially expressed between the three Treg subsets when a ra-
tio  2 in three independent experiments or confirmation
by other techniques was presupposed (Fig. S2 available at
http://www.jem.org/cgi/content/full/jem.20031562/
DC1). Intriguingly, many molecules associated with effec-
tor/memory differentiation or homing mechanisms ap-
peared to be differentially regulated between the Treg sub-
sets. In general, the largest differences were found between
 E
 CD25  and  E
 CD25  cells, whereas the double posi-
tive  E
 CD25  subset often displayed intermediate levels
of mRNA expression. A smaller number of genes was
found to be expressed at higher levels in  E
 CD25  than
in   E
 CD25  cells, including CCR7 and L-selectin
(CD62L) (2–5 fold difference), whereas the majority
of genes showed higher levels in  E
 CD25  than in
 E
 CD25  cells, including molecules such as CD44,
ICOS, granzyme B, FucTVII, integrin  1, CD54, CCR2,
CXCR3, CCR6, and Ki67 (2–10 fold difference), which
have been associated with activation and effector/memory
Figure 1. Foxp3 expression in Treg subsets. Foxp3 mRNA expression
was determined in sorted Treg subsets by real-time quantitative RT-PCR.
Obtained values were normalized to the housekeeping gene hypoxanthine
phosphoribosyltransferase and expressed as percentage of the level found
in CD25 single positive cells (mean   SD of three independent experiments). E 7 Identifies Effector/Memory-like Regulatory T Cells 306
status. Because the Affymetrix MG-U74Av2 microarray
did not admit evaluation of Foxp3, we additionally per-
formed a quantitative RT-PCR and observed a high
Foxp3 expression level in all three Treg subsets in compar-
ison to naive T cells (Fig. 1).
To confirm the differences observed by gene profiling,
we performed quantitative RT-PCR (Table SI available at
http://www.jem.org/cgi/content/full/jem.20031562/
DC1) and surface stainings on CD4  T cells for several
molecules used as markers to discriminate naive and anti-
gen-experienced T cells, or known as costimulatory and
adhesion molecules involved in lymphocyte trafficking
(Fig. 2). CD45RB expression was reduced in all three Treg
subsets in comparison with the predominantly naive con-
trol cells ( E
 CD25 ), as reported previously (18). How-
ever, the  E-expressing subsets and especially  E
 CD25 
cells showed significantly lower CD45RB levels than
CD25 single positive cells (P   0.01). This pattern (a na-
Figure 2. Phenotyping for
effector/memory markers as well
as adhesion molecules unravels a
high degree of heterogeneity
among Treg subsets. FACS®
analysis of pooled spleen and
lymph node cells shows the ex-
pression of several effector/
memory markers and adhesion
molecules on indicated CD4  T
cell subsets. Representative histo-
gram plots from three independent
experiments were selected show-
ing stainings (gray) plus isotype
controls (white). The graphs
summarize data from one repre-
sentative experiment and show
frequency or mean fluorescence
intensity of the indicated subsets
as mean   SD from three inde-
pendently analyzed animals.Huehn et al. 307
ivelike phenotype of CD25 single positive and an effector/
memory-like phenotype of  E-expressing cells) was even
more obvious for two other well-established markers,
CD44 and L-selectin. Additionally, a large number of fur-
ther adhesion and costimulatory molecules known to be as-
sociated with an effector/memory status, such as CD54
(intercellular adhesion molecule 1), ICOS,  1-integrin
(CD29), or LFA-1, were expressed at higher levels or on a
greater fraction of cells among the  E
  subsets. In general,
 E
 CD25  cells showed intermediate expression levels
(CD44, CD54, and LFA-1) or a more heterogeneous dis-
tribution (CD45RB, L-selectin, ICOS, and  1-integrin).
In contrast, another differentially expressed activation
marker, CD69, displayed the highest frequency among the
 E
 CD25  subset.
The expression profiles demonstrate developmental het-
erogeneity among the Treg subsets and suggest that  E
 
cells, in contrast with CD25 single positive cells, might be
induced or expanded in response to antigenic stimulation.
The latter hypothesis was tested by analysis of the TREC
number, which is an indicator of the proliferative history of
T cells: naive T cells without any antigen encounter and
only low homeostatic proliferation display a high TREC
content, whereas the frequency of excision circle positive
cells is strongly reduced in subsets that have undergone ex-
cessive proliferation (24). As shown in Fig. 3, CD25 single
positive cells contained a relatively high TREC num-
ber,  comparable to  E
 CD25  control cells. However,
 E
 CD25  and especially  E single positive cells showed
significantly lower TREC numbers, indicating that they
have undergone repetitive cell divisions.
 E
  Treg Subsets Display an Inflammation-seeking Pheno-
type. The differential expression level of adhesion mole-
cules not only distinguishes naive from effector/memory
cells, but also has important implications for their migration
behavior. As aforementioned, L-selectin was high on
CD25 single positive cells and low on a large part of  E
 
cells. L-Selectin enables entry into lymph nodes via high
endothelial venules and is crucial for recirculation of naive
cells. In contrast, cells that extravasate into inflamed areas
require expression of ligands for E- and P-selectin (25).
When we analyzed the E- and P-selectin binding capacity
of the Treg subsets using recombinant E- and P-selectin–Ig
chimera, respectively, we observed striking differences
between the subsets (Fig. 2). Reactivity with selectin
chimeras was detected among  E
  Treg subsets, whereas
 E
 CD25  cells, comparable to predominantly naive
 E
 CD25  cells, showed no E-selectin and only little
P-selectin binding.
That  E
  cells display an inflammation-seeking pheno-
type was further supported by the differential expression of
 1- and  2-integrins, known to synergize with selectins and
chemokines in the extravasation process and to mediate
firm adhesion to endothelium in lymphoid, nonlymphoid,
and inflammatory sites. Both the  1-chain and the  2-inte-
grin LFA-1 were found to be increased on  E
  cells (Fig.
2). In conclusion, Tregs that are equipped with a whole set
of adhesion molecules that allow them to migrate into pe-
ripheral tissues and inflamed sites are highly enriched
within  E-expressing Treg subsets.
Differences in Chemokine Responsiveness. Chemokines
have important functions in guiding distinct subsets of leu-
kocytes into specific tissues or into inflamed areas. To con-
firm the results from the cDNA microarrays, where differ-
ential expression of several chemokine receptors between
Treg subsets was observed, we performed quantitative RT-
PCR (Table SI). In support of the microarray data, we ob-
served an increased expression of CXCR3 mRNA on
 E
 CD25  and especially on  E
 CD25  cells compared
with the  E
 CD25  subset. Additionally,  E single positive
cells showed a slightly enhanced expression of CXCR4
mRNA compared with both CD25  subsets. No signifi-
cant differences were observed for CCR5 and CCR9 ex-
pression. In discordance to the microarray data, quantita-
tive RT-PCR revealed slightly higher values for CCR7
mRNA expression in the  E
  subsets compared with the
CD25 single positive cells, by unknown reasons. To get
conclusive results, especially on functional properties, we
performed chemotaxis assays, which also take into account
that chemokine responsiveness often dissociates from re-
ceptor expression (26). For these assays, we took un-
touched total T cells freshly isolated from lymphoid organs
and analyzed the responsiveness of the different subsets
contained therein. All Treg subsets harbored high frequen-
cies of cells responding toward the CCR7 ligand CCL19
(ELC), however,  E
 CD25  cells reproducibly showed a
significantly higher migratory response toward CCL19 than
both  E-expressing subsets in four experiments (Fig. 4). A
contrasting pattern was found for the inflammatory
chemokines CXCL9 (Mig), CCL17 (TARC), and also for
CCL20 (LARC), which bind to the receptors CXCR3,
CCR4, and CCR6, respectively. Both,  E
 CD25  and es-
pecially   E single positive cells displayed a significantly
higher responsiveness toward these inflammatory chemo-
kines than did CD25 single positive cells (Fig. 4). Titration
of selected chemokines assured that the graduated response
Figure 3.  E-expressing Treg subsets have undergone excessive prolif-
eration. Sorted Treg subsets from pooled spleen and lymph node cells
were analyzed for their TREC content. Shown is the TREC number
per 1,000 cells of the indicated subsets as mean   SD of three parallel
samples from one representative out of six independent measurements.
Significance (*, P   0.05) was computed from the six means. The average
TREC number per 1,000 cells in CD4 CD8  thymocytes (“high con-
trol”) and cultured Th1 cells (“low control”) was 80 and 1, respectively
(not depicted). E 7 Identifies Effector/Memory-like Regulatory T Cells 308
is not merely caused by different response curves (unpub-
lished data). Furthermore, we tested CCL2 (MCP-1) and
CCL4 (MIP-1 ), which bind to the receptors CCR2 and
CCR5, respectively. CCL2 and CCL4 did not induce a
significant migration of freshly isolated cells at chemokine
concentrations of 10 nM or 0.1–10 nM, respectively (un-
published data). In conclusion,  E
  cells respond preferen-
tially to several inflammatory chemokines, whereas the
CD25 single positive subset is more reactive to chemokines
involved in recirculation through lymphoid tissues.
Differential Migration Patterns of Treg Subsets In Vivo.
The phenotyping of Treg subsets for adhesion molecules
and chemokine responsiveness supported a concept in
which the Treg compartment can be subdivided into na-
ivelike CD25 single positive cells that preferentially migrate
into lymph nodes, and into effector/memory-like  E-
expressing cells that predominantly enter peripheral tissues
and inflamed effector sites. To test this hypothesis under in
vivo conditions, we performed homing experiments using
Treg subpopulations freshly isolated from lymphoid organs.
An isolation method with a combination of negative selec-
tion and preferential use of Fab fragments was used, to
avoid distribution artifacts due to beads or interfering levels
of Fc-bearing IgG remaining on the surface of the migrat-
ing cells. Sorted subsets were radioactively labeled and in-
jected i.v. into recipient mice. After 24 h, mice were killed,
and their organs were analyzed.
First, we investigated the migration behavior of  E
 
CD25 ,  E
 CD25 , and  E
 CD25 CD4  Treg subsets, as
well as  E
 CD25  CD4  T cells as a control population, in
untreated mice (Fig. 5 A). CD25 single positive cells showed
a higher migration rate into peripheral and mesenteric
lymph nodes compared with  E-expressing Tregs. In con-
trast, both  E-expressing subsets showed a significantly
higher migration rate into the liver. A similar pattern was al-
ready detectable at 3 h after injection (unpublished data).
Next, we tested the migration of Treg subsets in a model
of acute skin inflammation. Skin sensitization and challenge
with DNFB induces a strong inflammatory response ac-
companied by ear swelling and immigration of T effector
cells (25). 24 h after challenge, radioactively labeled Treg
subsets were injected i.v., and 24 h later, radioactivity in
the inflamed or control ear pinna was measured. Striking
differences between the analyzed subsets were recorded
with respect to their ability to immigrate into the inflamed
area (Fig. 5 B). Only  E single positive cells showed an effi-
cient migration into the inflamed skin, whereas migration
into the noninflamed control site was low. Accumulation
of both  E
 CD25  and CD25 single positive cells over
24 h was not significantly different from predominantly na-
ive ( E
 CD25 ) control cells, indicating that  E
 CD25 
are unique in their ability to travel into sites of acute skin
inflammation, as predicted from their homing and chemo-
kine receptor expression profiles.
Only  E-expressing Treg Subsets Are Capable of Suppressing
Acute Inflammatory Reactions. Recently, we have shown
that  E-expressing Treg subsets can efficiently inhibit the
development of an intestinal inflammation in the induced
SCID colitis model (18). Whether these subsets also can
suppress acute inflammatory reactions in nonlymphopenic
models and whether this is linked to their preferential mi-
gration into inflamed sites was tested in antigen-induced
Figure 4.  E-expressing subsets have a higher migratory capacity toward
inflammatory chemokines. The chemotactic response of pooled spleen
and lymph node T cells to 30 nM CCL19, 100 nM CXCL9, 100 nM
CCL17, and 10 nM CCL20 was analyzed in an in vitro chemotaxis assay.
The number of migrating cells of each subset was measured by flow
cytometry. Results are expressed as the percentage of the indicated subset
that migrated to the lower chamber and where normalized to the mean
migration rate of all subsets. Shown is the mean   SD of three (CCL17,
CCL20) or four (CCL19, CXCL9) experiments (*, P   0.05; **, P  
0.01). Basal migration toward medium alone (dotted lines) showed no
significant differences between the subsets.
Figure 5. CD25 single positive
cells display a stronger migration
into lymph nodes, but  E single
positive cells can efficiently enter
inflamed sites. (A) Radioactively
labeled T cell subsets were injected
i.v. into naive Balb/c mice fol-
lowed by the determination
of radioactivity in the indi-
cated organs after 24 h using a
 -counter. Percentage of total
recovered radioactivity is shown
(n   4; mean   SD; one representative out of two independent experiments). (B) Radioactively labeled T cell subsets were injected i.v. in Balb/c mice
that had been sensitized and challenged with DNFB. Recovered radioactivity from control and inflamed ear pinna was determined after 24 h (n   6;
mean   SD; *, P   0.05; **, P   0.01).Huehn et al. 309
arthritis (23). This model has previously been shown to be
a T cell–dependent autoimmune model, with an acute, an-
tigen-reactive phase and autoreactivity developing in the
chronic phase (27, 28).
Mice were immunized s.c. with mBSA, and arthritis was
induced by injection of mBSA into one knee joint. 1 d be-
fore arthritis induction, preactivated Treg or control subsets
were adoptively transferred into the mice. In this model,
preactivation of the polyclonal Treg subsets is required to get
an optimal suppression of the antigen-induced immune re-
sponse (unpublished data). Control experiments showed that
preactivation did not change the migration pattern of the
Treg subsets. Furthermore, all adoptively transferred subsets
survived equally well in vivo (Fig. S3 available at http://
www.jem.org/cgi/content/full/jem.20031562/DC1).
The measurement of knee joint swelling at various time
points revealed that only  E-expressing Treg subsets could
efficiently inhibit the acute inflammation (Fig. 6 A), with es-
pecially the  E
 CD25  cells displaying a high suppressive
capacity. Adoptive transfer of CD25 single positive cells had
no curative effect on knee joint swelling, which was similar
to mice receiving control cells ( E
 CD25 ) or PBS only.
Histological examinations of knee joints in the chronic phase
of arthritis revealed that mice receiving  E-expressing Treg
subsets had reduced mononuclear infiltrates, whereas marked
inflammatory signs were observed in mice adoptively trans-
ferred with CD25 single positive cells (Fig. 6 B and Fig.
S4 available at http://www.jem.org/cgi/content/full/jem.
20031562/DC1). Lack of suppression by CD25 single posi-
tive cells and antiinflammatory activity of  E-expressing Tregs
was also found in a transgenic, Th1-mediated footpad de-
layed-type hypersensitivity model (unpublished data).
Finally, we analyzed the migration behavior of the Treg
subsets in this arthritis model. Radioactively labeled T cell
subsets were injected i.v. 4 d after arthritis induction when
inflammatory signs in the knee joint were clearly visible
(23). Consistent with previous studies on effector cells (25),
24 h after transfer, a small percentage ( 0.5%) of total la-
beled cells could be found in the inflamed knee. Both  E-
expressing subsets showed a significantly higher migration
rate into the inflamed site compared with CD25 single pos-
itive and  E
 CD25  control cells (Fig. 6 C). A similar mi-
gration pattern was observed for the contralateral knee
joint, which in this model shows minor signs of inflamma-
tion, too. No recruitment of any subset was seen in knee
joints of nonimmunized animals (unpublished data). In
summary, using antigen-induced arthritis as a model, we
were able to show a correlation of the suppressive capacity
of  E-expressing Treg subsets with their preferential migra-
tion into inflamed sites.
Discussion
Functional and Phenotypic Heterogeneity of Tregs. Previ-
ous analyses suggested a considerable functional and pheno-
typic heterogeneity among Tregs (1). Gene expression pro-
filing is useful to reveal unique patterns of gene usage and
to identify molecular pathways involved in specific proper-
ties. We took advantage of our previous finding that ex-
pression of the integrin  E 7 subdivides murine Tregs into
subsets, which differ with respect to suppressive and other
functional capacities (18), and performed a detailed study
on their expression profile. Important findings were con-
firmed by flow cytometry, quantitative RT-PCR, and
functional assays.
The results revealed fundamental differences between
 E
  and  E
  populations, which suggests that this marker is
useful to distinguish distinct lineages or differentiation
stages of murine Tregs. A restricted number of genes was
reproducibly found to be differentially expressed between
the subsets. Besides markers for activation or memory status
and molecules involved in homing, which are discussed in
more detail below, some molecules emerged (e.g., S100A6
[calcyclin], S100A11 [calpactin I], and granzyme B) that
have been shown in former gene expression analyses to be
exclusively expressed in CD25  versus CD25 CD4  T
cell subsets (19). However, by subdividing the CD25 
compartment into  E
  and  E
  subsets and adding  E
 
CD25  cells to the analysis, we can demonstrate that these
genes do not segregate with CD25, but are predominantly
Figure 6.  E-expressing subsets
show the strongest suppression of
inflammatory reactions in antigen-
induced arthritis. (A and B)
mBSA-immunized C57Bl6 mice
received 105 FACS®-sorted and
polyclonally preactivated cells
24 h before intraarticular mBSA
injection ( E
 CD25 ,  n     4;
 E
 CD25 , n   4;  E
 CD25 ,
n   11;  E
 CD25 , n   11; and
PBS alone, n     10). (A) The
progression of arthritis was monitored by the measurement of knee joint swelling (mean   SD; one representative out of two independent experiments).
 E
 CD25  and  E
 CD25  cells showed a higher suppressive capacity than CD25 single positive cells (P   0.01 and P   0.085, respectively). (B) At day
14, tissues were taken for histological examination. The final arthritis score was evaluated for each animal (mean   SEM; one representative out of two
independent experiments).  E
+CD25+ cells showed a significantly lower arthritis score than CD25 single positive cells (*, P   0.05). (C) Radioactively
labeled T cell subsets were injected i.v. in mBSA-immunized mice that had received an intraarticular mBSA injection 4 d before the homing experiment.
Recovered radioactivity from the inflamed knee was determined after 24 h using a  -counter. Percentage of total recovered radioactivity is shown (n   6;
mean   SD; one representative out of two independent experiments).  E
 CD25  and  E
 CD25  cells showed a significantly higher migration into the
inflamed knee joint compared with CD25 single positive cells (*, P   0.05). E 7 Identifies Effector/Memory-like Regulatory T Cells 310
expressed within  E
  subsets, supporting the concept of a
heterogeneous Treg compartment.
Consistently, the data indicate that CD25 single positive
cells resemble naive T cells, displaying high expression of
L-selectin and higher CCR7 responsiveness as well as low
expression of CD44 and other adhesion molecules and,
somewhat less pronounced, higher CD45RB levels. In
contrast, the  E single positive population shows typical
features of effector/memory cells, including expression of
receptors required for immigration into peripheral and in-
flamed tissues. The increased mRNA levels for CD25 on
 E single positive cells (compared with CD45RBhigh cells)
and surface expression of CD25 upon activation in vitro
(unpublished data) might suggest that the  E
 CD25  sub-
set, which also expresses higher levels of CD69, merely
represents an activated stage of  E single positive cells.
However, all other markers related to activation and differ-
entiation into effector/memory stage, including CD44,
L-selectin, and several adhesion and chemokine receptors,
consistently favor the view that the  E
 CD25  subset repre-
sents an intermediate stage or a more heterogeneous popula-
tion in between CD25 and  E single positive cells and does
not originate from the  E single positive subset. This is con-
firmed by the content of TRECs, which is high in CD25
single positive and lowest in  E single positive cells, indicat-
ing that the former represent a rather naive developmental
stage, whereas the latter cells are those that have most often
divided after TCR recombination within the thymus (24).
A model recently suggested by Bluestone et al. reconciles
the functional and developmental heterogeneity among
Tregs in proposing the existence of natural and adaptive
regulators differing not only in terms of origin but also of
specificity and effector mechanisms (11). According to their
model, natural, self-antigen–specific Tregs develop during
the normal process of T cell maturation in the thymus and
survive as a long-lived population in the periphery, poised
to sustain self-tolerance. In contrast, adaptive Tregs de-
velop upon T cell activation under particular conditions.
Several sets of data in the present work provide evidence
that the expression of CD25 and  E can be used to differ-
entiate these subsets in the murine system; their differential
developmental stage according to TREC content and ef-
fector/memory markers as well as unique migratory phe-
notypes consistently define them as distinct subsets. Appar-
ently, CD25 single positive and  E-expressing cells can be
envisaged as prototypes of natural and adaptive Tregs, re-
spectively, with the adaptive regulators developing either
from thymus-derived natural Tregs or from naive cells
upon encounter with cognate antigen (Fig. 7). In accor-
dance with this, only CD25 single positive cells were de-
tected in significant frequencies among CD4 CD8  cells
in thymus early after birth (unpublished data).
Expression of  E 7 at very high levels is a hallmark of in-
traepithelial lymphocytes residing in the gut wall and other
epithelial compartments, such as skin and lung (29). It is
tempting to speculate that  E
  Tregs isolated from second-
ary lymphoid organs originate from these compartments.
However, we did not find significant in vitro suppressive
capacity among total  E
 CD4  cells isolated from the gut
wall (unpublished data). However, not excluded is the
presence of a subpopulation representing developing Tregs
in this compartment. Furthermore,  E 7 can be induced
upon activation in presence of TGF  (30); therefore, its
expression might be seen as an indication of their previous
maturation in a TGF -rich milieu. Consistent with the
view that  E
  regulators originate in response to peripheral
antigen, transfer studies with antigen-specific T cells into
mice that express the antigen under organ-specific promot-
ers in the periphery reveal an induction of the integrin
 E 7 on transgenic T cells (unpublished data). Whether the
same applies for the adoptively transferred CD25 CD4  T
cells, which recently have been reported to undergo exces-
sive in vivo proliferation under particular conditions (31,
32), remains to be shown. However, it is already known
that oral antigen application led to a reduction of L-selectin
levels on antigen-specific CD25 CD4  T cells (9, 33),
which suggests that these cells might belong to the
 E
 CD25  subset, which is predominantly L-selectinlow.
Migration Behavior and Different Suppressive Capacity In
Vivo. A critical issue as yet insufficiently addressed is the
question of where Tregs exert their suppressive function. Is
their presence in lymphoid tissue required to prevent devel-
opment of autoimmune reactions at initial stages of T cell
activation, or is it the effector site where suppression of au-
toaggressive cells occurs that have escaped central tolerance
mechanisms? Our findings suggest that Tregs are able to act
at both stages, yet with a conspicuous division of labor be-
tween natural regulators recirculating through lymphoid tis-
sue and adaptive regulators equipped to migrate into in-
flamed tissues. The distinct migratory behavior of the Treg
subsets described in this paper emphasizes the importance of
subset localization for their suppressive capacity in vivo.
Some data suggest that Tregs are most efficient in pre-
venting priming of naive cells (12), which requires their
presence in lymphoid tissue. CD25 single positive cells dis-
Figure 7. CD25 single positive cells represent natural Tregs, whereas
 E-expressing subsets are prototypes of adaptive Tregs.Huehn et al. 311
play typical properties of recirculating T cells with high
levels of L-selectin and responsiveness toward CCR7
ligands, which both have been shown to be a prerequisite
for the migration into lymph nodes (34–36). Additionally,
the lack of homing and chemokine receptors for inflamma-
tory sites suggests that this population is unlikely to per-
form a function in acute inflammation. Indeed, here we
were able to directly demonstrate efficient trafficking into
lymphoid tissues but poor migration into inflamed sites.
A distinct function of the L-selectinhigh/CCR7high subset
of CD25 CD4  Tregs in the prevention of autoimmunity
has been described in the NOD model, where this subset
efficiently suppressed development of diabetes, indicating
that, in this model, the homeostatic regulation by naivelike
regulators is of major importance (14, 37). However, in
vitro studies did not reveal a higher suppressive potential of
the L-selectinhigh subset (19). These findings indicate that
the differential regulatory capacities of the L-selectinhigh and
L-selectinlow subsets in vivo reflect differences in homing
properties, rather than suppressor potential by itself. Inter-
estingly, those Tregs recovered from the inflamed islets
were L-selectinlow (14), suggesting that part of the regula-
tory cells might differentiate into the effector/memory
stage in vivo.
The present work shows that  E
  subsets represent the
lineage or developmental stage of adaptive, effector/mem-
ory-like regulators. Effector/memory cells preferentially lo-
calize within nonlymphoid and inflamed tissues, which
correlate with increased levels of a variety of adhesion mol-
ecules and chemokine receptors (25, 38–41). This was also
found for the  E-expressing subsets, notably for molecules
such as LFA-1,  1-integrin, CD44, ligands for inflamma-
tory selectins, and chemokine receptors. Furthermore,  E
 
Tregs showed increased trapping within the liver, a par-
tially LFA-1–dependent mechanism (42), which resembles
a similar feature of CD4  effector/memory or CD8  T
cells (43, 44). It is tempting to speculate that those T cells
with suppressive potential that could be isolated from effec-
tor sites such as synovial fluid of rheumatoid arthritis pa-
tients (45), lung tumors (46), transplants (47), skin lesions of
Leishmania major–infected mice (17), islets of Langerhans in
a diabetes model (48), or the inflamed intestine in the
SCID colitis model (49), might represent typical examples
of adaptive Tregs.
In most types of inflammation, E- and P-selectin play a
dominant role in recruiting effector cells (25, 39). Expres-
sion of ligands for both selectins as well as increased mes-
sage for the enzyme fucosyltransferase VII, which generates
the selectin-binding epitopes (50), was found to be a prom-
inent feature of  E
  cells. These findings have important
implications for the use of migratory pathways as targets for
antiinflammatory therapy; inhibition of such functions
might not only prevent the infiltration of autoaggressive ef-
fector cells but also that of protective regulators. This issue
has to be considered in therapeutic concepts.
 E
  Tregs also show high levels of mRNA for inflam-
matory chemokine receptors such as CCR2, CXCR3,
CCR4, and CCR5, which are absent on naive T cells, and
display increased responsiveness toward CXCL9/Mig and
CCL17/TARC. These data fit to a separate analysis of
L-selectinhigh and L-selectinlow subsets of murine CD25 
cells, which largely might correspond with CD25 single
positive and  E
 CD25  cells, respectively, revealing that
CCR7 is predominantly expressed on the L-selectinhigh
subset, whereas levels of CCR2, CCR4, and CXCR3
were much higher on CD25 L-selectinlow cells (37). Dif-
ferential expression of chemokine receptors might not only
effect tissue- or inflammation-specific migration, but also
guide subsets of T cells, including Tregs to different types
of antigen-presenting cells, as recently proposed (15, 51).
To what extent this might contribute to differential func-
tioning of Treg subsets is completely unknown.
Here, we provide direct evidence that the differential
expression of adhesion molecules and chemokine receptors
translates into different migratory properties in vivo. Espe-
cially  E single positive cells migrate very efficiently into
inflamed skin, where E/P-selectins as well as CCR4 ligands
play a predominant role (39, 52), whereas both  E-express-
ing subsets were efficiently recruited into inflamed joints.
The number of  E
  Tregs accumulating in the inflamed
tissues was similar to that of Th1 effector cells in the same
inflammatory models (reference 25 and unpublished data).
Previously, we have shown that  E single positive cells
efficiently prevent development of colitis in the SCID
model, although these cells display rather poor suppressive
capacity in vitro (18). By combining high in vitro suppres-
sive capacity with specific migration into effector sites,
 E
 CD25  cells showed the highest capacity to prevent in-
flammatory disease. In this lymphopenic model, Tregs un-
dergo extensive expansion in vivo (49) and it has been ar-
gued that even homeostatic competition suffices to obtain
protection (53). Here, we show that partial protection by
adoptive transfer of Treg subsets can also be demonstrated
in inflammatory models using immunocompetent mice,
and even when given after priming.  E single positive and
 E
 CD25  Treg subsets were both able to reduce acute
and chronic inflammation in antigen-induced arthritis. In
fact, CD25 single positive cells, which showed no prefer-
ential migration into the inflamed knee joint, were not
protective in the acute phase and showed only weak sup-
pressive effects on chronic inflammation.
Conversion of an established immune pathology by
Tregs has only been described recently (49). It is tempting
to predict that  E-expressing subsets, by combining high
suppressive potential with specific migration behavior into
inflamed sites, could have a strong therapeutic potential in
established autoimmune diseases. Immunosuppressive strat-
egies based on adoptive transfer of Tregs have to take this
requirement into account.
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